Effects of Esketamine Combined with Dexmedetomidine on Early Postoperative Cognitive Function in Elderly Patients Undergoing Lumbar Spinal Surgery: A Double-Blind Randomized Controlled Clinical Trial
Qing-Yu Tao,Dong Liu,Shi-Jie Wang,Xu Wang,Rui-Ning Ouyang,Jing-Yi Niu,Rende Ning,Jun-Ma Yu
DOI: https://doi.org/10.2147/dddt.s481173
IF: 4.3188
2024-11-28
Drug Design Development and Therapy
Abstract:Qing-Yu Tao, 1, &ast Dong Liu, 1, &ast Shi-Jie Wang, 2, &ast Xu Wang, 1 Rui-Ning Ouyang, 1 Jing-Yi Niu, 1 Rende Ning, 2 Jun-Ma Yu 1 1 Department of Anaesthesiology, The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei), Hefei, Anhui, 230061, People's Republic of China; 2 Department of Orthopaedics, The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei), Hefei, Anhui, 230061, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jun-Ma Yu, Department of Anaesthesiology, The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei), 390 huaihe Road, Hefei, Anhui, 230061, People's Republic of China, Tel +8655162183386, Email Rende Ning, Department of Orthopaedics, The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei), 390 huaihe Road, Hefei, Anhui, 230061, People's Republic of China, Tel +8655162189112, Email Background: Postoperative cognitive dysfunction (POCD) is a common complication after surgery in elderly patients, and its prevalence can be up to 25.6% at one week after noncardiac surgery. This study mainly evaluates the combined effects of esketamine and dexmedetomidine on the incidence of POCD in elderly patients undergoing lumbar spine surgery and explores the underlying mechanisms. Methods: A total of 162 elderly patients undergoing lumbar spine surgery were randomized into three groups: esketamine combined with dexmedetomidine group (ED group), esketamine group (E group), and dexmedetomidine group (D group). Primary outcome measures included the incidence of POCD on the first postoperative day. Secondary outcomes included the incidence of POCD on the third postoperative day, first postoperative day serum levels of neuron-specific enolase (NSE) and calcium-binding protein β (S100β), patient visual analog scale (VAS) scores at 2, 24, and 48 hours postoperatively, and the incidence of adverse events. Results: The incidence of POCD on the first postoperative day was significantly lower in the ED group compared to the E group ( P = 0.017), with no significant differences when compared to the D group ( P = 0.064). The levels of serum NSE in patients in the ED group on the first postoperative day were significantly lower than those in E group and D group (ED group vs E group, P = 0.028; ED group vs D group, P = 0.048). The results for the S100β were similar to those for the NSE (ED group vs E group, P = 0.005; ED group vs D group, P = 0.011). Conclusion: The combination of esketamine and dexmedetomidine effectively reduces the incidence of POCD on the first postoperative day in elderly patients undergoing lumbar spine surgery. Keywords: esketamine, dexmedetomidine, postoperative cognitive dysfunction, neuroinflammatory POCD is a common perioperative neurological complication that occurs after surgery in elderly patients and is characterized by a decline in cognitive function compared to preoperative cognitive function. 1 Unlike postoperative delirium (POD), which is characterized by disturbance in attention and awareness, emotion, cognition, and fluctuating severity of consciousness, POCD is primarily characterized by cognitive deficits, including impaired memory, perceptual functions, language, and task-assembly abilities. 2 Studies have shown that in elderly patients undergoing noncardiac surgery, the incidence of POCD was 25.6% at one week postoperatively and 9.9% at three months postoperatively. 3 More critically, POCD not only affects the recovery of patients, increases the economic burden of patients, but also may lead to the increase of patient mortality. 4,5 Consequently, developing effective strategies to mitigate POCD is an urgent and significant challenge. Numerous studies have identified older age and general anesthesia as major risk factors for POCD. 6,7 Current research about esketamine primarily focuses on its nasal spray use in treatment-resistant depression, 8,9 it is frequently utilized in specific anesthesia scenarios due to its higher bioavailability, rapid metabolism, potent analgesic properties, and fewer adverse effects compared to ketamine. 10 In the context of general anesthesia, esketamine has been shown to reduce opioid consumption, maintain hemodynamic stability, and decrease patient stress and postoperative pain. 11–13 A previous clinical study highlighted the neuroprotective effects of subanesthetic doses of -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal